Reoccurring disappointment in development portfolios-why it happens and how to mitigate it.
Gary Summers
Advertisement
Articles by Gary Summers
Advertisement
Latest Updated Articles
Product Development: The Optimizer’s CursePublished: September 19th 2019 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Technological Renaissance: AI’s Integration into the Pharmaceutical Industry
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
FDA's History with Complex Plants
4
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
5